Cargando…
A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythropoietic protoporphyria
Autores principales: | Ducamp, Sarah, Luscieti, Sara, Ferrer-Cortès, Xènia, Nicolas, Gaël, Manceau, Hana, Peoc’h, Katell, Yien, Yvette Y., Kannengiesser, Caroline, Gouya, Laurent, Puy, Herve, Sanchez, Mayka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252951/ https://www.ncbi.nlm.nih.gov/pubmed/33596641 http://dx.doi.org/10.3324/haematol.2020.272450 |
Ejemplares similares
-
The role of ClpX in erythropoietic protoporphyria
por: Whitman, Jared C., et al.
Publicado: (2018) -
Erythropoietic protoporphyria
por: Lecha, Mario, et al.
Publicado: (2009) -
Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria
por: Mirmiran, Arienne, et al.
Publicado: (2020) -
Microcytosis in Erythropoietic Protoporphyria
por: Graziadei, Giovanna, et al.
Publicado: (2022) -
Evidence in the UK Biobank for the underdiagnosis of erythropoietic protoporphyria
por: Dickey, Amy K., et al.
Publicado: (2020)